AI Analysis AI Analysis of NPCE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NPCE to Watchlist?
Some Reasons Why To Add NPCE:
  • +79.7% price growth over the last year
  • High gross margin of 78.3%
  • Highly efficient cash conversion (104% FCF/OCF ratio)
PDF

NeuroPace, Inc. stock downgraded to Hold/Accumulate
(Updated on Jul 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jul 02, 2026 Gain 6.01%

The NeuroPace, Inc. stock price gained 0.82% on the last trading day (Friday, 10th Jul 2026), rising from $16.97 to $17.11. During the last trading day the stock fluctuated 4.05% from a day low at $16.54 to a day high of $17.21. The price has risen in 7 of the last 10 days and is up by 4.58% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 253 more shares were traded than the day before. In total, 90 thousand shares were bought and sold for approximately $1.54 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect NeuroPace, Inc. stock with a 90% probability to be traded between $14.79 and $18.91 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

NPCE Signals & Forecast

The NeuroPace, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $16.84 and $16.24. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -3.88%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for NeuroPace, Inc. stock

NeuroPace, Inc. finds support from accumulated volume at $16.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.670 between high and low, or 4.05%. For the last week, the stock has had daily average volatility of 4.69%.

Our recommended stop-loss: $16.24 (-5.06%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (NPCE) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect NeuroPace, Inc. to open at $16.95, and during the day (based on 14 day Average True Range), to move between $16.71 and $17.51, which gives a possible trading interval of +/-$0.799 (+/-4.78%) up or down from last closing price. If NeuroPace, Inc. takes out the full calculated possible swing range there will be an estimated 4.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $16.47 (3.74%) than the resistance at $18.12 (5.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is NeuroPace, Inc. stock A Buy?

NeuroPace, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.667 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $16.95 ( 0.92%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NPCE Performance

Trading levels for NPCE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 17.62 3.00%
R2 17.37 1.50%
R1 17.21 0.580%
Price 17.11
S1 16.70 -2.41%
S2 16.54 -3.34%
S3 16.28 -4.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 19.29 12.74%
R2 18.35 7.25%
R1 18.12 5.90%
Price 17.11
S1 16.47 -3.74%
S2 15.81 -7.60%
S3 15.67 -8.42%

FAQ

What is the symbol for NeuroPace, Inc. Stock and on which exchange is it traded?
The symbol for NeuroPace, Inc. is NPCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroPace, Inc. Stock?
NeuroPace, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy NeuroPace, Inc. Stock?
NeuroPace, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroPace, Inc. Stock.

What's the current price of NeuroPace, Inc. Stock?
As of the end of day on the Jul 10, 2026, the price of an NeuroPace, Inc. (NPCE) share was $17.11.

What is the 52-week high and low for NeuroPace, Inc. Stock?
The 52-week high for NeuroPace, Inc. Stock is $19.60 and the 52-week low is $7.56.

What is the market capitalization of NeuroPace, Inc. Stock?
As of the Jul 10, 2026, the market capitalization of NeuroPace, Inc. is 583.344M.

When is the next earnings date for NeuroPace, Inc.?
The upcoming earnings date for NeuroPace, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT NEUROPACE, INC.
NeuroPace
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE